SpacemiT K3 challenges Nvidia Jetson with 60-TOPS AI performance. Explore the new Pico-ITX and CoM260 developer kits for RISC ...
A multicenter phase II study of modified FOLFIRINOX for first-line treatment for advanced urachal cancer (ULTMA; KCSG GU20-03). This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I.